Management Forum Logo

Presented by
Management Forum

Metered Dose Inhaler (MDI) Technology Training Course

A comprehensive overview of MDIs including development, manufacture, regulation and market potential

★★★★★ "Mr. David has an amazing teaching skill, making complex content accessible (even for a non-native sp... more"

19-20 June 2025
+ 8-9 October 2025 »
from £1299

Need help? Enrol/reserve

Format: Live online
CPD: 12 hours for your records
Certificate of completion

Course overview

This interactive course will provide a comprehensive overview of metered-dose inhaler technology past, present and future, giving participants a valuable insight into market potential and recent industry trends. The programme will clarify the therapeutic targets and look at the various delivery technologies available. There will be detailed coverage of the current environmental, regulatory and economic pressures and how these impact, development, manufacturing process, equipment and options, together with quality and inspection requirements, human factors and bioequivalence. Our highly experienced trainer will address the regulations applying to inhalation products and provide guidance on the regulatory pathways to follow.

The event will benefit those new to this area and will also be of value to anybody who requires a refresher on the opportunities available with this technology. The seminar format will include practical workshops, which past delegates have found invaluable, and ample opportunity for discussion on any specific issues with an expert in this field.

This course is part of our range of Medical Devices training courses

Who should attend?

Respiratory pharma professionals who need to understand MDI technology and its opportunities
Medical device professionals new to working in the area of MDIs or those who need a refresher
Development and regulatory professionals, with a development or product portfolio including MDIs, who need an understanding of future demands
Medical device business development managers
Respiratory professionals in R&D
Medical device manufacturers working in the respiratory market

Enrol/reserve

This course will cover:

Day 1
Day 2

Therapeutic targets

A brief history of inhalation and MDI therapy
The lung as a target
Respiratory diseases
Systemic delivery
Therapeutic considerations
Life limiting Vs Life threatening

Markets past, present and future

Geographic - Challenges and opportunities
Disease prevalence
Economic considerations
International demand
Modelling opportunity (what to consider)

MDI Technology

How and Why MDIs work
MDI Formulation approaches
The elements of an MDI
Key performance characteristics
MDI Feature/ Functions compared to other dosage forms
Add-On technologies for MDIs
Are there limits to MDI technology?

Workshop I

Ranking of competitive technologies for different opportunities

MDI Manufacture

Key Process steps (space, services, staff)
Environment (Controls)
Equipment (Scale, design, options etc.)
Process controls & Inspection
Safety and Quality
Quality by Design (QbD) approaches
Manufacturing and cost

MDI Testing

What and when to test
How to test
How not to test
Demonstrating equivalence

Regulation of MDIs

Legislation
Regulatory guidance
Consensus standards
Pharmacopoeial requirements

Developing an MDI

The MDI as a drug-device combination product
Applying Design Controls
Human Factors & Usability
Risk management

Workshop II

SWOT MDI vs multi-dose DPI
SWOT MDI vs soft mist inhaler

MDIs and the environment

Inhaler Carbon Footprint
Environmental pressures on MDIs
Alternate propellants (Alternate problems?)
Alternate design approaches
Recycling - Technical and patient considerations

The future of the MDI

Summary of the Course
What opportunities does the future hold?
Workshop

Enrol/reserve

David Howlett
Pharma Delivery Solutions

In 2003 David established PharmaDelivery Solutions Ltd as a specialised consultancy service in the field of drug delivery combination products (especially respiratory) device technology. This has led to involvement in projects with focus in pulmonary, nasal and other delivery routes, with an international client base. Much of the activity of PharmaDelivery Solutions Ltd is focused in the area of development programme support, regulatory GAP analysis and generation of documentation supporting development and test programmes, together with data review and contingency evaluation.

David has over 35 years experience in the development, industrialization and approval of inhalation drug delivery systems, combination products and medical devices.

PharmaDelivery Solutions Ltd has provided input ranging from GAP analysis and comment to complete remedial implementation in areas including

• Design Control
• Risk Management
• Materials strategies
• Regulatory documentation
• Technical reviews and opinion

In addition to activities supporting commercial organizations, David has been involved in the following roles;

Honorary Teaching Fellow in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester and is author/ tutor for the Pharmaceutical Industry Advanced Training (PIAT) MSc module on Inhalation dosage forms.

A UK national expert representing the British Standards Institute on ISO TC84 developing new international standards for pulmonary and nasal delivery devices syringes and catheters.

David has also worked with the United Nations and various national governments to develop and establish transition strategies from the use of CFC in Metered Dose Inhalers and to secure appropriate budgets from the Multi-lateral fun for the implementation of the Montreal Protocol in emerging markets around the world.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

30% off the 2nd delegate*
40% off the 3rd delegate*
50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

19-20 June 2025

Live online

09:30-17:15 UK (London) (UTC+01)
10:30-18:15 Paris (UTC+02)
04:30-12:15 New York (UTC-04)
Timings may be different for each day
Course code 14763

GBP 1,299 1,499
EUR 1,819 2,099
USD 2,087 2,399

Until 15 May

2 days live online training
Browser-based, no download usually required
See presenters and interact with fellow attendees
Download documentation and certification of completion
Fair transfer and cancellation policy

View basket

Not ready to book yet?

for 7 days, no obligation

8-9 October 2025

Live online

09:30-17:15 UK (London) (UTC+01)
10:30-18:15 Paris (UTC+02)
04:30-12:15 New York (UTC-04)
Timings may be different for each day
Course code 14987

GBP 1,299 1,499
EUR 1,819 2,099
USD 2,087 2,399

Until 03 Sep

2 days live online training
Browser-based, no download usually required
See presenters and interact with fellow attendees
Download documentation and certification of completion
Fair transfer and cancellation policy

View basket

Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's Metered Dose Inhaler (MDI) Technology training course

The material was very informative and presented by David in a way that was easy to understand, with good diagrams and analogies that helped with the understanding. Good balance of the technical aspects, history and options for the future.

Feb 26 2024

Simon Barton United States of America
Director - Device CoE, AstraZeneca

Mar 27 2023

Mr. David has an amazing teaching skill, making complex content accessible (even for a non-native speaker as I am).

Victor Panzeri Brazil
R&D Analyst, Eurofarma Laboratórios SA

Sep 18 2019

I was hoping for further improvement of my understanding of the matter of inhalational drugs, especially MDI, and this expectation was fully met. The speakers had superb knowledge of the subject, vast experience and a great sense of humour.

Robin Boehm Germany
Team Leader Regulatory Submissions - New Products, STADA Arzneimittel AG